FDA’s Diversity Action Plan may set a new paradigm for trial transparency

FDA’s Diversity Action Plan may set a new paradigm for trial transparency

Submitted by admin on July 30, 2024 - 11:46am
Source: 
Cl
News Tags: 
FDA
regulatory
clinical trials
clinical trial diversity
Headline: 
FDA’s Diversity Action Plan may set a new paradigm for trial transparency
snippet: 

Following the release of the FDA’s guidance, sponsors must now specify their rationale and goals for clinical study enrolment.

Do Not Allow Advertisers to Use My Personal information